. Author manuscript; available in PMC: 2018 Jun 12.

Published in final edited form as: J Clin Psychopharmacol. 2018 Feb;38(1):34–41. doi: 10.1097/JCP.0000000000000829

Table 5.

Sensitivity Analysis with Estimated Effects and ORs (95% CI) of Varenicline Dose on Abstinence Controlling for Unobserved Covariates with a Varying Population Prevalence of a Possible Confounder

Prevalence	0.01% OR (95% CI)	10% OR (95% CI)	15% OR (95% CI)	20% OR (95% CI)	25% OR (95% CI)	30% OR (95% CI)
Treatment effect
3-month abstinence	2 (1.2–4.1)	2.1 (1.1–3.8)	2.1 (1.1–3.7)	2.1 (1.1–3.7)	2.1 (1.1–3.7)	2 (1.1–3.6)
6-month abstinence	2.4 (1.3–4.3)	2.2 (1.2–4)	2.2 (1.2–3.9)	2.2 (1.2–3.9)	2.1 (1.2–3.8)	2.1 (1.2–3.8)
9-monthabstinence	2.3 (1.3–3.9)	2.1 (1.2–3.6)	2.1 (1.2–3.6)	2.1 (1.2–3.5)	2.1 (1.2–3.5)	2 (1.2–3.5)

Abbreviations: OR, odds ratio; CI, confidence interval.